Clinical Trial Update: Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing sirolimus versus tacrolimus in African-American kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Prograf (Tacrolimus)
• Rapamune (sirolimus)

Snippet

Sponsor: Wayne State University | Conditions: Kidney Transplantation | Phase 4 | Status: UNKNOWN